Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Oleclumab
Trade Name
Synonyms MEDI9447
Drug Descriptions

Oleclumab (MEDI9447) is a monoclonal antibody against NT5E (CD73), resulting in activation of an anti-tumor immune response by preventing the conversion of AMP to adenosine in the tumor microenvironment (PMID: 27622077).

DrugClasses Adenosine Targeting 23 CD73 Antibody 12
CAS Registry Number 1803176-05-7
NCIT ID C123914


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
AZD4635 + Oleclumab AZD4635 Oleclumab 0 2
Carboplatin + Durvalumab + Oleclumab Carboplatin Durvalumab Oleclumab 0 0
Carboplatin + Durvalumab + Oleclumab + Paclitaxel Carboplatin Durvalumab Oleclumab Paclitaxel 0 1
Cisplatin + Durvalumab + Oleclumab Cisplatin Durvalumab Oleclumab 0 0
Durvalumab + Fluorouracil + Leucovorin + Oleclumab + Oxaliplatin Durvalumab Fluorouracil Leucovorin Oleclumab Oxaliplatin 0 2
Durvalumab + Gemcitabine + Nab-paclitaxel + Oleclumab Durvalumab Gemcitabine Nab-paclitaxel Oleclumab 0 2
Durvalumab + Gemcitabine + Oleclumab Durvalumab Gemcitabine Oleclumab 0 0
Durvalumab + IPH5201 + Oleclumab Durvalumab IPH5201 Oleclumab 0 1
Durvalumab + Nab-paclitaxel + Oleclumab Durvalumab Nab-paclitaxel Oleclumab 0 0
Durvalumab + Oleclumab Durvalumab Oleclumab 0 12
Durvalumab + Oleclumab + Paclitaxel Durvalumab Oleclumab Paclitaxel 0 1
Durvalumab + Oleclumab + Pemetrexed Disodium Durvalumab Oleclumab Pemetrexed Disodium 0 0
Fluorouracil + Leucovorin + Oleclumab + Oxaliplatin Fluorouracil Leucovorin Oleclumab Oxaliplatin 0 1
Gemcitabine + Nab-paclitaxel + Oleclumab Gemcitabine Nab-paclitaxel Oleclumab 0 1
Oleclumab Oleclumab 0 1
Oleclumab + Osimertinib Oleclumab Osimertinib 0 1

Additional content available in CKB BOOST